sb 239063 has been researched along with Carcinoma, Hepatocellular in 1 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, PC | 1 |
| Ke, XF | 1 |
| Kuang, HL | 1 |
| Pan, LL | 1 |
| Ye, Q | 1 |
| Wu, JB | 1 |
1 other study available for sb 239063 and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
BMP2 secretion from hepatocellular carcinoma cell HepG2 enhances angiogenesis and tumor growth in endothelial cells via activation of the MAPK/p38 signaling pathway.
Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Bone Morphogenetic Protein 2; Carcinoma, Hepatoc | 2019 |